Heart failure management: the impact of drug therapy on survival.

[1]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[2]  R. A. Johnson,et al.  Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.

[3]  M. Packer.  How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men. , 1987, Journal of the American College of Cardiology.

[4]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[5]  Thomas C. Gibson,et al.  The prevalence of congestive heart failure in two rural communities. , 1966, Journal of chronic diseases.

[6]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[7]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[8]  S. Yusuf,et al.  Potential for altering the natural history of congestive heart failure: need for large clinical trials. , 1985, The American journal of cardiology.

[9]  M. Cheitlin,et al.  Long-term digitalis therapy improves left ventricular function in heart failure. , 1980, The New England journal of medicine.

[10]  M. Packer,et al.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. , 1983, Circulation.

[11]  C. Furberg,et al.  Effect of vasodilators on survival in chronic congestive heart failure. , 1985, The American journal of cardiology.

[12]  M. Pfeffer,et al.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.

[13]  B. Massie,et al.  Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses. , 1984, Circulation.

[14]  R M Gardner,et al.  "Anaerobic threshold": problems of determination and validation. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[15]  W. M. Smith.  Epidemiology of congestive heart failure. , 1985, The American journal of cardiology.

[16]  H. White,et al.  Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. , 1985, The American journal of cardiology.

[17]  Y. Taguma,et al.  Effect of captopril on heavy proteinuria in azotemic diabetics. , 1985, The New England journal of medicine.

[18]  R. Jones,et al.  Use of maximal bicycle exercise testing with respiratory gas analysis to assess exercise performance in patients with congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[19]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.

[20]  R. Gillum,et al.  Heart failure in the United States 1970-1985. , 1987, American heart journal.